R01DK131107
Project Grant
Overview
Grant Description
The small intestinal microbiota in undernourished women and undernourished children in Bangladesh: Identifying causal mechanisms and therapeutic targets - Project Summary/Abstract
Childhood undernutrition is a global health challenge manifested by impaired ponderal growth (wasting/acute malnutrition), impaired linear growth (stunting), immune and metabolic dysfunctions, altered CNS development, plus other abnormalities. Over 30 million children worldwide suffer from moderate acute malnutrition (MAM), with prevalence anticipated to worsen significantly with the COVID-19 pandemic. Globally, 159 million children are stunted. Current treatments have limited effectiveness.
By analyzing serially collected fecal samples from healthy members of Bangladeshi birth cohorts and those with MAM, we found that MAM is associated with impaired microbiota development (microbiota immaturity). We have developed a microbiota-directed formulation of complementary foods that repairs their microbiota, resulting in significantly greater improvements in ponderal growth compared to an existing nutritional intervention, and revealing mechanisms by which microbiota members are linked to host mediators of healthy growth.
The role of the small intestinal (SI) microbiota in childhood undernutrition remains enigmatic in part because of the difficulty in obtaining samples. Associations between altered SI absorptive function, asymptomatic enteropathogen infection, and stunting have led to the hypothesis that subclinical enteric dysfunction contributes to growth faltering. Environmental enteric dysfunction (EED) is an SI enteropathy of unknown etiology first described in adult Peace Corps volunteers returning from areas of high fecal-oral contamination, with diarrhea, intestinal malabsorption, reduced villus height/number, and gut barrier function disruption. Studies of EED have relied on non-validated fecal or plasma biomarkers, making its contribution to childhood undernutrition ill-defined.
Our Bangladesh Environmental Enteric Dysfunction (BEED) study involved endoscopy of stunted children who failed a nutritional intervention, which revealed a group of SI bacterial taxa whose absolute abundances negatively correlate with linear growth. A cultured consortium of these duodenal taxa produced SI enteropathy in recipient gnotobiotic mice. We now propose to test the hypothesis that the SI microbiota contributes to SI enteropathy and malnutrition (low-BMI) in women of childbearing age and, via transmission to their children, to perpetuate intergenerational undernutrition.
Our four specific aims will compare the SI microbiota plus the duodenal mucosal and plasma proteomes of malnourished Bangladeshi women (BMI < 18.5 kg/m2) of childbearing age with histopathologic evidence of enteropathy versus those with normal BMIs (20-24.9 kg/m2) and no histopathologic evidence of enteropathy. We will determine whether their SI microbiota transmits SI enteropathy and impaired growth to gnotobiotic mice, ascertain whether these phenotypes are prevented/rescued by SI microbial community members from normal-BMI Bangladeshi women without enteropathy, and screen biochemically-diverse plant polysaccharides in our mouse models for their effects on enteropathy/growth, with leads advanced to gnotobiotic piglets.
Childhood undernutrition is a global health challenge manifested by impaired ponderal growth (wasting/acute malnutrition), impaired linear growth (stunting), immune and metabolic dysfunctions, altered CNS development, plus other abnormalities. Over 30 million children worldwide suffer from moderate acute malnutrition (MAM), with prevalence anticipated to worsen significantly with the COVID-19 pandemic. Globally, 159 million children are stunted. Current treatments have limited effectiveness.
By analyzing serially collected fecal samples from healthy members of Bangladeshi birth cohorts and those with MAM, we found that MAM is associated with impaired microbiota development (microbiota immaturity). We have developed a microbiota-directed formulation of complementary foods that repairs their microbiota, resulting in significantly greater improvements in ponderal growth compared to an existing nutritional intervention, and revealing mechanisms by which microbiota members are linked to host mediators of healthy growth.
The role of the small intestinal (SI) microbiota in childhood undernutrition remains enigmatic in part because of the difficulty in obtaining samples. Associations between altered SI absorptive function, asymptomatic enteropathogen infection, and stunting have led to the hypothesis that subclinical enteric dysfunction contributes to growth faltering. Environmental enteric dysfunction (EED) is an SI enteropathy of unknown etiology first described in adult Peace Corps volunteers returning from areas of high fecal-oral contamination, with diarrhea, intestinal malabsorption, reduced villus height/number, and gut barrier function disruption. Studies of EED have relied on non-validated fecal or plasma biomarkers, making its contribution to childhood undernutrition ill-defined.
Our Bangladesh Environmental Enteric Dysfunction (BEED) study involved endoscopy of stunted children who failed a nutritional intervention, which revealed a group of SI bacterial taxa whose absolute abundances negatively correlate with linear growth. A cultured consortium of these duodenal taxa produced SI enteropathy in recipient gnotobiotic mice. We now propose to test the hypothesis that the SI microbiota contributes to SI enteropathy and malnutrition (low-BMI) in women of childbearing age and, via transmission to their children, to perpetuate intergenerational undernutrition.
Our four specific aims will compare the SI microbiota plus the duodenal mucosal and plasma proteomes of malnourished Bangladeshi women (BMI < 18.5 kg/m2) of childbearing age with histopathologic evidence of enteropathy versus those with normal BMIs (20-24.9 kg/m2) and no histopathologic evidence of enteropathy. We will determine whether their SI microbiota transmits SI enteropathy and impaired growth to gnotobiotic mice, ascertain whether these phenotypes are prevented/rescued by SI microbial community members from normal-BMI Bangladeshi women without enteropathy, and screen biochemically-diverse plant polysaccharides in our mouse models for their effects on enteropathy/growth, with leads advanced to gnotobiotic piglets.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Saint Louis,
Missouri
63130
United States
Geographic Scope
Single Zip Code
Related Opportunity
Washington University was awarded
SI Microbiota in Undernourished Women & Children in Bangladesh
Project Grant R01DK131107
worth $3,038,963
from the National Institute of Diabetes and Digestive and Kidney Diseases in September 2021 with work to be completed primarily in Saint Louis Missouri United States.
The grant
has a duration of 3 years 8 months and
was awarded through assistance program 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
The Project Grant was awarded through grant opportunity NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).
Status
(Complete)
Last Modified 6/5/24
Period of Performance
9/21/21
Start Date
5/31/25
End Date
Funding Split
$3.0M
Federal Obligation
$0.0
Non-Federal Obligation
$3.0M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for R01DK131107
Transaction History
Modifications to R01DK131107
Additional Detail
Award ID FAIN
R01DK131107
SAI Number
R01DK131107-383228997
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NK00 NIH NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
Funding Office
75NK00 NIH NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
Awardee UEI
L6NFUM28LQM5
Awardee CAGE
2B003
Performance District
MO-01
Senators
Joshua Hawley
Eric Schmitt
Eric Schmitt
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Health and Human Services (075-0884) | Health research and training | Grants, subsidies, and contributions (41.0) | $2,044,312 | 100% |
Modified: 6/5/24